title: SDHD-related chromaffin tumours: disease localisation to genetic dysfunction.
abstract: OBJECTIVE
  To describe the management of a subject with multiple chromaffin tumours found to have a novel succinate dehydrogenase D (SDHD) mutation.
  
  
  METHODS
  A 15-year-old boy with marked hypertension was found to have elevated urinary catecholamines and initial imaging thought to represent bilateral adrenal phaeochromocytomas. An adrenal venous catheter was required to clarify a right adrenal phaeochromocytoma and a left abdominal paraganglioma, distinct from the left adrenal gland. Excision of these tumours, with preservation of the left adrenal gland, provided a cure for this subject without the need for lifelong steroid replacement. Genetic analysis revealed a novel SDHD mutation (c. 169 + 1 G>A) which was shown to result in loss of the 5' splice site and exclusion of exon 2 during splicing. This suggests the likely pathogenicity of this mutation. Disease surveillance in this subject and genetic screening of first degree relatives is ongoing.
  
  
  CONCLUSIONS
  Genetic testing should be considered in all subjects presenting with a chromaffin tumour. In certain circumstances an adrenal venous sampling catheter for catecholamines may clarify diagnostic uncertainty. The complex management issues raised in the care of these subjects requires the involvement of a multidisciplinary team with the relevant expertise.
authors.affiliation: Department of Endocrinology, St Bartholomew's Hospital, London, UK. u.srirangalingam@qmul.ac.uk
authors.forename: U
authors.initials: U
authors.lastname: Srirangalingam
authors.forename: B
authors.initials: B
authors.lastname: Khoo
authors.forename: M
authors.initials: M
authors.lastname: Matson
authors.forename: R
authors.initials: R
authors.lastname: Carpenter
authors.forename: R
authors.initials: R
authors.lastname: Reznek
authors.forename: E R
authors.initials: ER
authors.lastname: Maher
authors.forename: S L
authors.initials: SL
authors.lastname: Chew
authors.forename: W M
authors.initials: WM
authors.lastname: Drake
mesh_terms: D000008:Abdominal Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000601:surgery; D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000601:surgery; D001794:Blood Pressure; D002395:Catecholamines / Q000097:blood / Q000235:genetics* / Q000652:urine; D002404:Catheterization / Q000379:methods; D019439:Chromaffin Cells / Q000201:enzymology / Q000473:pathology; D005091:Exons; D006801:Humans; D008297:Male; D009154:Mutation; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000601:surgery; D010235:Paraganglioma / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000601:surgery; D010673:Pheochromocytoma / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000601:surgery; D022821:RNA Splice Sites; D012326:RNA Splicing; D013385:Succinate Dehydrogenase / Q000235:genetics*
chemical_list: D002395:Catecholamines; D022821:RNA Splice Sites; C491545:SDHD protein, human; D013385:Succinate Dehydrogenase